 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 April 2001 | Volume 134 Issue 7 | Pages 600-620
Purpose: To review critically the available data on diagnostic evaluation, risk stratification, and therapeutic management of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD).
Data Sources: English-language articles were identified by searching MEDLINE (1966 to 2000, week 5), EMBASE (1974 to 2000, week 18), HealthStar (1975 to June 2000), and the Cochrane Controlled Trials Register (2000, Issue 1).
Study Selection: The best available evidence on each subtopic was selected for analysis. Randomized trials, sometimes buttressed by cohort studies, were used to evaluate therapeutic interventions. Cohort studies were used to evaluate diagnostic tests and risk stratification.
Data Extraction: Study design and results were summarized in evidence tables. Individual studies were rated by internal validity, external validity, and quality of design. Statistical analyses of combined data were not performed.
Data Synthesis: Data on the utility of most diagnostic tests are limited. However, chest radiography and arterial blood gas sampling seem useful while acute spirometry does not. Identifiable clinical variables are associated with risk for relapse and risk for death after hospitalization for an acute exacerbation. Evidence of efficacy was found for bronchodilators, corticosteroids, and noninvasive positive-pressure ventilation. There is also support for the use of antibiotics in patients with more severe exacerbations. On the basis of limited data, mucolytics and chest physiotherapy do not seem to be of benefit, and oxygen supplementation seems to increase the risk for respiratory failure only in an identifiable subgroup of patients.
Conclusions: Although suggestions for appropriate management can be made on the basis of available evidence, the supporting literature is scarce and further high-quality research is necessary. Such research will require an improved, generally acceptable, and transportable definition of acute exacerbation of COPD, as well as improved methods for observing and measuring outcomes.
Author and Article Information
From Memorial Sloan-Kettering Cancer Center, New York, New York; and the Center for Clinical Health Policy Research, Duke Evidence-Based Practice Center, and Duke University Medical Center, Durham, North Carolina.
This paper will also appear in Chest (2001; volume 119).
Annals of Internal Medicine encourages readers to copy and distribute this paper, providing such distribution is not for profit. Commercial distribution is not permitted without the express permission of the publisher.
Disclaimer: The authors of this article are responsible for its contents, including any clinical or treatment recommendations. No statement in this article should be construed as an official position of the Agency for Healthcare Research and Quality of the U.S. Department of Health and Human Services.
Grant Support: By the American College of Physicians–American Society of Internal Medicine, American College of Chest Physicians, and the Agency for Healthcare Research and Quality (contract no. 290-97-0014).
Acknowledgments: This article is based on research conducted by investigators at Memorial Sloan-Kettering Cancer Center, New York, New York, under contract with the American College of Physicians–American Society of Internal Medicine (ACP–ASIM) and the American College of Chest Physicians (ACCP), and by investigators at Duke University, Durham, North Carolina, under contract with the Agency for Healthcare Research and Quality (contract no. 290-97-0014). The authors thank the combined ACP–ASIM/ACCP Expert Panel; the Evidence-Based Center peer review and technical advisory panels; Ruth E. Goslin, MAT; and Rebecca N. Gray, DPhil.
Requests for Single Reprints: Peter B. Bach, MD, MAPP, Health Outcomes Research Group, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 221, New York, NY 10021.
Current Author Addresses: Dr. Bach and Ms. Gelfand: Health Outcomes Research Group, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 221, New York, NY 10021.
Dr. Brown: 350 Bell Building, Box 3221, Duke University Medical Center, Durham, NC 27710.
Dr. McCrory: 2200 West Main Street, Suite 230, Duke University Medical Center, Durham, NC 27705. POSITION PAPER
Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  M. E. Falagas, S. G. Avgeri, D. K. Matthaiou, G. Dimopoulos, and I. I. Siempos Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis J. Antimicrob. Chemother., September 1, 2008; 62(3): 442 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Todd, R. A. McIvor, S. O. Pugsley, and G. Cox Approach to chronic obstructive pulmonary disease in primary care Can Fam Physician, May 1, 2008; 54(5): 706 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. MacIntyre and Y. C. Huang Acute Exacerbations and Respiratory Failure in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 530 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Leo, N. Venissac, D. Pop, P. Solli, P. Filosso, A. Minniti, D. Radice, and J. Mouroux Postoperative exacerbation of chronic obstructive pulmonary disease. Does it exist? Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 424 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Polverino, F. P. Gomez, H. Manrique, N. Soler, J. Roca, J. A. Barbera, and R. Rodriguez-Roisin Gas Exchange Response to Short-Acting beta2-Agonists in Chronic Obstructive Pulmonary Disease Severe Exacerbations Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 350 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Komatsu, H. Kudoh, and Y. Kagawa Evaluation of Oxidative Stress and Effectiveness of Low-Dose Glucocorticoid Therapy on Exacerbation of Chronic Obstructive Pulmonary Disease J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2007; 62(4): 459 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Martinez and J. L. Curtis Procalcitonin-Guided Antibiotic Therapy in COPD Exacerbations: Closer But Not Quite There Chest, January 1, 2007; 131(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
|
|
P. Pasquina, M. R. Tramer, J.-M. Granier, and B. Walder Respiratory Physiotherapy To Prevent Pulmonary Complications After Abdominal Surgery: A Systematic Review Chest, December 1, 2006; 130(6): 1887 - 1899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Lindenauer, P. Pekow, S. Gao, A. S. Crawford, B. Gutierrez, and E. M. Benjamin Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, June 20, 2006; 144(12): 894 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Rodriguez-Roisin COPD exacerbations {middle dot} 5: Management. Thorax, June 1, 2006; 61(6): 535 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Bartlett Update in Infectious Diseases Ann Intern Med, January 3, 2006; 144(1): 49 - 56. [Full Text] [PDF]
|
|
|
|
|
|
B. Leff, L. Burton, S. L. Mader, B. Naughton, J. Burl, S. K. Inouye, W. B. Greenough III, S. Guido, C. Langston, K. D. Frick, et al. Hospital at Home: Feasibility and Outcomes of a Program To Provide Hospital-Level Care at Home for Acutely Ill Older Patients Ann Intern Med, December 6, 2005; 143(11): 798 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Woodhead, F. Blasi, S. Ewig, G. Huchon, M. Leven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, and T. J. M. Verheij Guidelines for the management of adult lower respiratory tract infections Eur. Respir. J., December 1, 2005; 26(6): 1138 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Matsuyama, H. Mitsuyama, M. Watanabe, K.-i. Oonakahara, I. Higashimoto, M. Osame, and K. Arimura Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Markers in COPD Chest, December 1, 2005; 128(6): 3817 - 3827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Aziz, A. I. Blamoun, M. K. Shubair, M. M.F. Ismail, V. A. DeBari, and M. A. Khan Serum Magnesium Levels and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Study Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 423 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Mentzelopoulos, M. Tzoufi, K. Rellos, A. S. Michalopoulos, E. Stamataki, C. Roussos, and S. G. Zakynthinos An Evaluation of McCoy Balloon Laryngoscopy in Patients With Moderate-to-Major Endotracheal Intubation Difficulty Anesth. Analg., October 1, 2005; 101(4): 1233 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A Spruit Enhanced physiotherapy management of acute exacerbations of chronic obstructive pulmonary disease Chronic Respiratory Disease, July 1, 2005; 2(3): 117 - 119. [PDF]
|
|
|
|
|
|
F. J. Martinez, R. F. Grossman, N. Zadeikis, A. C. Fisher, K. Walker, M. E. Ambruzs, and A. M. Tennenberg Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg Eur. Respir. J., June 1, 2005; 25(6): 1001 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chodosh Clinical Significance of the Infection-FreeInterval in the Management of Acute Bacterial Exacerbations of Chronic Bronchitis Chest, June 1, 2005; 127(6): 2231 - 2236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Dolovich, R. C. Ahrens, D. R. Hess, P. Anderson, R. Dhand, J. L. Rau, G. C. Smaldone, and G. Guyatt Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology Chest, January 1, 2005; 127(1): 335 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Tunis, D. B. Stryer, and C. M. Clancy Practical Clinical Trials: Increasing the Value of Clinical Research for Decision Making in Clinical and Health Policy JAMA, September 24, 2003; 290(12): 1624 - 1632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fournier, Z.-S. Huang, H. Li, X. Da, B. Cercek, and M. I. Lewis Insulin-like growth factor I prevents corticosteroid-induced diaphragm muscle atrophy in emphysematous hamsters Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R34 - R43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Patil, J. A. Krishnan, N. Lechtzin, and G. B. Diette In-Hospital Mortality Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease Arch Intern Med, May 26, 2003; 163(10): 1180 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Croxton, G. G. Weinmann, R. M. Senior, R. A. Wise, J. D. Crapo, and A. S. Buist Clinical Research in Chronic Obstructive Pulmonary Disease: Needs and Opportunities Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1142 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.D. Sin and S.F.P. Man Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter? Eur. Respir. J., February 1, 2003; 21(2): 260 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Barr and J. K. Stoller Acute Exacerbations of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., November 7, 2002; 347(19): 1533 - 1534. [Full Text] [PDF]
|
|
|
|
|
|
C. Sohy, C. Pilette, M.S. Niederman, and Y. Sibille Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Eur. Respir. J., May 1, 2002; 19(5): 966 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stey Acute Exacerbations of Chronic Obstructive Pulmonary Disease Ann Intern Med, April 2, 2002; 136(7): 556 - 557. [Full Text] [PDF]
|
|
|
|
|
|
J. K. Stoller Acute Exacerbations of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., March 28, 2002; 346(13): 988 - 994. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Williams, K. Blake, and H. W. Kelly Introduction: Pulmonary Medicine Journal of Pharmacy Practice, April 1, 2001; 14(2): 89 - 90. [PDF]
|
|
Article
